Valproic Acid Suppliers & Bulk Manufacturers
Available Forms: Tablet / Capsule/ Injection / Oral syrup
Available Strengths: 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
Category:
Neurology
Valproic Acid is available in Tablet / Capsule/ Injection / Oral syrup
and strengths such as 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Valproic Acid is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Valproic Acid can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Valproic acid (VPA) is a widely used medication with diverse therapeutic applications in neurology and psychiatry. It is primarily indicated for the treatment of epilepsy across various seizure types, management of bipolar disorder, and prevention of migraine headaches. VPA works by enhancing inhibitory neurotransmission in the brain and modulating voltage-gated ion channels, which helps stabilize neuronal activity and prevent abnormal electrical discharges.
Effective use of valproic acid requires careful coordination among healthcare professionals, including neurologists, psychiatrists, pharmacists, and nurses. Proper patient selection, individualized dosage adjustment, and ongoing monitoring are essential to maximize therapeutic benefits while minimizing potential risks. VPA therapy also necessitates consideration of drug interactions and adverse effects, which can vary based on patient age, comorbidities, and co-administered medications.
Valproic acid has been studied extensively in special populations, including pediatric patients, pregnant women, and older adults, to ensure safe and effective use. Communication between healthcare providers, patients, and caregivers is crucial for promoting adherence, understanding potential side effects, and optimizing treatment outcomes. Its proven efficacy, broad clinical applications, and well-established pharmacology make valproic acid a cornerstone therapy in neurological and psychiatric care.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing